SS Innovations International, Inc.
SSIIHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeSS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman,. Valued at $728.5M, SSII is a small-cap name in its sector. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems.
Market Cap
$728.5M
Beta
0.56
P/E (TTM)
—
P/E (Fwd)
-60.67
EPS (TTM)
$-0.05
EPS (Fwd)
$-0.06
ROE
-21.1%
ROA
-4.8%
Cash
$16.0M
Total Debt
$13.8M
Free CF
-$124,139
52W Change
-54.1%
Annual Financials
Cash vs Debt
With $16.0M in cash and $13.8M in debt, SSII maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company is burning cash, with free cash flow at -$124K. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -21.1%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $1.4M (2022) to $42.5M (2025), reflecting a 2858% increase over the period.
With a beta below 0.7, SS Innovations International, Inc. typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence SS Innovations International, Inc.'s trajectory.